Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Azria

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trialAlain Toledano, David Azria, Pascal Garaud, et al.
Frontiers in Oncology|July 5, 2021
Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical ReviewPaul Sargos, Mame Daro Faye, Manon Bacci, et al.
ISRN Urology|May 9, 2012
Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer CenterOlivier Riou, Pascal Fenoglietto, Benoit Laliberté, et al.
World Journal of Radiology|September 21, 2016
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapyOlivier Lauche, Youlia M Kirova, Pascal Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 17, 2025
Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?Chloé Buchalet, Constance Golfier, Jean-Christophe Faivre, et al.
International Journal of Molecular Sciences|May 13, 2014
Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancerAgnes V Tallet, David Azria, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patientsMahmut Ozsahin, Nigel E A Crompton, Sophie Gourgou, et al.
Bulletin Du Cancer|May 20, 2020
[COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie]Pascale Grosclaude, David Azria, Rosine Guimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomasChristel Larbouret, Bruno Robert, Isabelle Navarro-Teulon, et al.
The British Journal of Radiology|March 13, 2025
Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancersDavid Azria, Joanne S Haviland, Muriel Brengues, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trialAlain Toledano, David Azria, Pascal Garaud, et al.
Frontiers in Oncology|July 5, 2021
Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical ReviewPaul Sargos, Mame Daro Faye, Manon Bacci, et al.
ISRN Urology|May 9, 2012
Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer CenterOlivier Riou, Pascal Fenoglietto, Benoit Laliberté, et al.
World Journal of Radiology|September 21, 2016
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapyOlivier Lauche, Youlia M Kirova, Pascal Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 17, 2025
Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?Chloé Buchalet, Constance Golfier, Jean-Christophe Faivre, et al.
International Journal of Molecular Sciences|May 13, 2014
Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancerAgnes V Tallet, David Azria, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patientsMahmut Ozsahin, Nigel E A Crompton, Sophie Gourgou, et al.
Bulletin Du Cancer|May 20, 2020
[COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie]Pascale Grosclaude, David Azria, Rosine Guimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomasChristel Larbouret, Bruno Robert, Isabelle Navarro-Teulon, et al.
The British Journal of Radiology|March 13, 2025
Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancersDavid Azria, Joanne S Haviland, Muriel Brengues, et al.
Pageof 25